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http:WHAT THIS PAPER ADDS
This is the ﬁrst randomized trial including two centers comparing the fascia suture technique with a suture-
mediated closure device in patients having endovascular treatment of aortic aneurysms and dissections. The
study brings information about access closure time and cost and also the complication rate for both techniques
and independent risk factors for failure.Objectives: The aim was to investigate whether the fascia suture technique (FST) can reduce access closure time
and procedural costs compared with the Prostar technique (Prostar) in patients undergoing endovascular aortic
repair and to evaluate the short- and mid-term outcomes of both techniques.
Methods: In this two center trial, 100 patients were randomized to access closure by either FST or Prostar
between June 2006 and December 2009. The primary endpoint was access closure time. Secondary outcome
measures included access related costs and evaluation of the short- and mid-term complications. Evaluation was
performed peri- and post-operatively, at discharge, at 30 days and at 6 months follow up.
Results: The median access closure time was 12.4 minutes for FST and 19.9 minutes for Prostar (p < .001).
Prostar required a 54% greater procedure time than FST, mean ratio 1.54 (95% CI 1.25e1.90, p < .001) according
to regression analysis. Adjusted for operator experience the mean ratio was 1.30 (95% CI 1.09e1.55, p ¼ .005)
and for patient body mass index 1.59 (95% CI 1.28e1.96, p < .001). The technical failure rate for operators at
proﬁciency level was 5% (2/40) compared with 28% (17/59) for those at the basic level (p ¼ .003). The proﬁciency
level group had a technical failure rate of 4% (1/26) for FST and 7% (1/14) for Prostar, p ¼ 1.00, while
corresponding rates for the basic level group were 27% (6/22) for FST and 30% (11/37) for Prostar (p ¼ .84).
There was a signiﬁcant difference in cost in favor of FST, with a median difference of V800 (95% CI 710e927,
p < .001).
Conclusions: In aortic endovascular repair FST is a faster and cheaper technique than the Prostar technique.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 2 February 2014, Accepted 3 October 2014, Available online 27 December 2014
Keywords: Endovascular aneurysm repair, Randomized controlled trial, Cost analysis, Procedure time, Fascia
suture, Percutaneous closureEndovascular repair of abdominal aortic aneurysm (EVAR)
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//dx.doi.org/10.1016/j.ejvs.2014.10.021aneurysm repair (P-EVAR) utilizing a suture mediated
closure device (SMCD) was ﬁrst described in 1999 by Haas
et al.3 P-EVAR may reduce surgery time and decrease time
to ambulation4 but the procedural cost may increase.5 The
overall success rate for percutaneous closure is reported to
be 89e95%4,6e11 with a 6 month complication rate of about
2%.6 Obesity, femoral calciﬁcation, tortuous iliac arteries
and scarred groins have been proposed as risk factors for
complications.7,11e13
The fascia suture technique (FST) was described by
Diethrich14 in 1997 and was evaluated by this group in
2006.15 With this technique, access closure can be provided
without exposure of the vessel. The method requires a
RCT of Fascia Suture Versus Suture Mediated Closure Device 167dissection to the femoral fascia and is not percutaneous. The
overall reported success rate is in the same range as for
SMCD. Reported studies are, however, retrospective and
mid-term results are not fully documented, or FST has been
combined with external compression.15e18 Uncertainty ex-
ists about how well FST compares with other techniques and
no randomized studies have been performed previously.
The aim of this study was to investigate whether FST
reduces the time and cost of the procedure in comparison
to pre-suturing using the Prostar XL percutaneous Vascular
Surgical system (Abbott Laboratories, Redwood City, CA,
USA) and to evaluate the short- and mid-term outcome of
both techniques.
METHODS
Study design
From June 2006 to December 2009 a prospective, ran-
domized, two center trial was performed in EVAR or
thoracic endovascular aortic repair for aneurysm or
dissection. The primary endpoint was procedure time for
access closure for FST and Prostar. Secondary outcome
measures included access related costs and evaluation of
short- and mid-term complications of both techniques.
Patients planned for endovascular treatment with a need
of at least a 16F (outer diameter) introducer/stent graft
system in the main femoral access site were included.
Exclusions included the need for aorto-uni-ilac (AUI)
stentgrafts with femoro-femoral or other bypass involving
the main femoral access site, femoral aneurysms, ruptured
aneurysms, emergency operations when pre-operative ul-
trasound was not performed, ongoing anticoagulation, and
patients previously included in the trial or patients not
considered likely to attend follow up. Availability of physi-
cians with experience of both closure techniques, “closure
license,” was mandatory.
The Regional Ethical Review Board approved the study
and patient informed consent was obtained prior to
enrolment. The trial is registered ISRCTN68739781. Örebro
University Hospital, Sweden, funded the trial.Participating centers
Two centers (Örebro University Hospital and Sahlgrenska
University Hospital, Göteborg) participated in the trial.
Operators were required to have experience of 15 FST and
15 Prostar procedures and to have reached the basic level in
order to participate. The proﬁciency level for the closure
techniques was set at 60 procedures.Randomization
Örebro research center handled computer generated
randomization, designed with equal probability (1:1 ratio)
of assignment to either FST or Prostar by means of con-
cealed allocation and stratiﬁcation by center using a
permuted block design. Sealed opaque envelopes imprinted
with a randomization number were delivered to the hos-
pitals. Randomization was performed in the operating roomor the angiography suite when all required baseline data
had been collected, femoral access had been performed,
and a guidewire and an introducer (maximum 10F) had
been inserted.
Sample size
A power calculation demonstrating 10 minutes difference in
closure time (90% power, signiﬁcance level 5%) between
the groups required 22 patients in each group at each
center, based on an estimated mean of 13 minutes (FST)
and 23 minutes (Prostar) (SD 9), (ManneWhitney U test).
90 patients were going to be enrolled, but in the end an
additional 10 patients were randomized before enrolment
was closed.
Access closure
Fascia suture. Technical details of the FST have been
described previously.15 After completion of the main part of
the endovascular procedure, time from the intended start
of closure of the femoral puncture, to completion of skin
suture was recorded.
Prostar. The Prostar XL device was used in accordance with
the “preclose” technique.3 A minimum of two devices were
required. The time from when the ﬁrst Prostar device was
inserted to when the sutures of the second Prostar device
were secured (step 1) was recorded. After completion of
the endovascular procedure the time for step 2 between
when the sutures were released and completion of skin
suture was recorded.
Procedures and follow up
Endovascular procedure. The centers used their standard
protocols for endovascular repair. All patients received
5,000 units of heparin after a large bore introducer or a
graft sheath had been inserted, and the activated clotting
time (ACT) was monitored and kept at 200e250 seconds.
No protamine was administered.
Outcome. Outcome was recorded peri-operatively, post-
operatively, at discharge, at 30 days, and at 6 months
follow-up. Technical success was deﬁned as hemostasis
without the need for immediate open surgical repair or
external compression. Peri-operative, post-operative, and
late access related (index site) complications included any
event leading to an additional procedure, operative or non-
operative, or the ﬁnding of a pseudoaneurysm.
Adverse events and additional procedures related to the
index site at discharge and at 1 and 6 months were
recorded.
Measurements. A pre-operative duplex ultrasound was
performed of the common femoral artery (CFA), the distal
5 cm of the external iliac artery, the proximal 5 cm of the
superﬁcial femoral artery, and the deep femoral artery.
Signiﬁcant stenosis (>50%, deﬁned as doubled ﬂow veloc-
ity) and occlusions were recorded. Thrombosis of the
common femoral vein was recorded. At 6 months
Figure 1. CONSORT diagram showing ﬂow of patients through trial.
FST ¼ fascia suture technique.
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was noted and its size determined.
The ankleebrachial pressure index (ABI) was measured in
both legs pre-operatively, at discharge and at 1 and 6
months.
Cost analysis. Closure time during the primary procedure
was registered in minutes and seconds. Procedure time for
reoperations related to the index site was registered in
minutes, and additional procedures requiring another hos-
pital stay were recorded as number of days. The cost for the
operations was calculated according to the respective hos-
pital’s price per minute of operating time, and for hospital
stay the standard price per day for patients treated outside
the catchment area was used. Costs for disposables, such as
the Prostar device, and sutures used for closure of the index
site were included. The mean of each center’s prices was
used for all calculations.
Statistics. Mean (SD) was used for continuous variables and
the median (range) was calculated for a non-normal distri-
bution; percentages were calculated for categorical vari-
ables. Procedure time differences were handled with the
ManneWhitney U test and then with linear regression to
adjust for operator experience and body mass index (BMI)
as potential confounders. Because of a skewed distribution,
procedure time was evaluated logarithmically, which gives
mean ratios as measures of association from linear regres-
sion. A mean ratio of 1 between study groups is interpreted
as no association and a mean ratio of 1.5 as a 50% longer
mean procedure time in one group. Differences in cate-
gorical variables between study groups were analyzed using
the chi-square test or the Fischer exact test when appro-
priate. To adjust for operator experience in the evaluation of
complication differences between groups, logistic regres-
sion was used, giving odds ratios (ORs) as the measure of
association. A KaplaneMeier plot with log rank test was
used to compare study groups for the time to the ﬁrst ac-
cess related complication and to reintervention. Hodgese
Lehmann’s method19 was used for cost analysis (95% CI for
median differences of total cost between study groups). A p
value <.05 was considered statistically signiﬁcant. SPSS
version 17 (Chicago, IL, USA) and STATA release 11 (College
Station, TX, USA) were used for analyses.RESULTS
Study population
Between June 2006 and May 2009, 122 patients were
screened for the trial. Before randomization, 22 patients
were excluded, six due to exclusion criteria, two due to co-
morbidities, two rescheduled for open or hybrid repair. Four
patients had died. Five patients could not be randomized
because the endovascular operator had not fulﬁlled the
minimum volume of procedures, and there were three
protocol violations. One hundred patients were randomized
(Örebro 54, Gothenburg 46); 99 patients were eligible for
analysis. Fig. 1 shows the trial ﬂow. The risk factors ofpatients were registered according to the Swedish Vascular
Registry20; BMI and antiplatelet and anticoagulation treat-
ment were noted (Table 1).
One patient randomized to the fascia suture group was
converted to an AUI and femoro-femoral bypass procedure.
Per-protocol analysis was therefore performed in 99 pa-
tients. The groups were well matched for baseline charac-
teristics except for overweight and operator experience,
which were more common in the FST group than in the
Prostar group (Table 1).Procedural details
Procedures were performed by endovascular surgeons
(74%) or interventional radiologists (26%).
Commercially available devices were used for all endo-
vascular repairs. The total surgical time was 184 minutes
(SD 66) in the FST group compared with 194 minutes (SD
86) in the Prostar group (p ¼ .523). There was no difference
between introducer/stent graft outer diameter. One fascia
suture was sufﬁcient in 71% and maximum two sutures
were used in 92% of the procedures. Two Prostar devices
were used in 88% of the procedures (Table 2).Access closure time
The median procedure time for closure was 12.4 minutes
for FST and 19.9 minutes for Prostar, p < .001 (Fig 2).
Prostar required 54% longer procedure time than FST
(regression analysis, mean ratio 1.54 [95% CI 1.25e1.90,
Table 2. Access related (index site) procedural details.
FST Prostar
n ¼ 48 n ¼ 51
Introducer/stentgraft
Maximum OD 21.0 (1.8) 21.0 (1.9)
Fascia suture
1 suture 34 (71%)
2 sutures 10 (21%)
3 sutures 3 (6%)
4 sutures 1 (2%)
Prostar
2 devices 45 (88%)
3 devices 5 (10%)
4 devices 1 (2%)
Abbreviations: OD ¼ outer diameter.Data are presented as mean
(SD) or number of patients and percentage.
Figure 2. Box plot of access closure time by fascia suture technique
(FST) and Prostar. Note. The boxes represent the 75th and 25th
percentiles; the horizontal bar within a box is the median; the
whiskers are max and min if no outliers are present, otherwise
open circles (B) represent outliers: values >1.5 box lengths from
the 25th or 75th percentile. The asterisk (*) represents extremes:
values >3 box lengths from the 25th or 75th percentile.
Table 1. Demographics.
FST Prostar
Patients
Patients (number of patients) 48 51
Age, mean (SD) 76.3 (6.7) 74.6 (8.2)
Gender, female (%) 8 (17%) 9 (18%)
Anatomical location/pathology
Abdominal aortic aneurysm 42 (88%) 38 (74%)
Thoracic aortic aneurysm 3 (6%) 7 (14%)
Iliac aneurysm 2 (4%) 6 (12%)
Thoracic aortic dissection 1 (2%) 0 (0%)
Indication
Primary elective 44 (92%) 45 (88%)
Secondary electivea 4 (8%) 5 (10%)
Acute 0 (0%) 1 (2%)
Risk factorsb
Cerebrovascular 6 (13%) 7 (14%)
Diabetes 6 (13%) 8 (16%)
Hyperlipidemia 16 (33%) 20 (39%)
Hypertensive diseasec 37 (77%) 38 (75%)
Cardiac 26 (54%) 27 (53%)
Previous vascular surgery or
amputation
7 (15%) 10 (20%)
Pulmonary 8 (17%) 11 (22%)
Renal 3 (6%) 6 (12%)
Smoking 13 (27%) 16 (31%)
BMId
Normal range (18.5e24.9) 13 (27%) 24 (47%)
Overweight (25.0e29.9) 25 (52%) 19 (37%)
Obese class IeIII (30.0) 10 (21%) 8 (16%)
Drug therapy
Platelet inhibition 28 (58%) 32 (63%)
Anticoagulation 8 (17%) 7 (14%)
Operators
Proﬁciency level 26 (54%) 14 (27%)
Basic level 22 (46%) 37 (73%)
Data are presented as mean (SD) or number of patients and
percentage.
a Previous endovascular treatment of aorta has been performed.
b Risk factors according to guidelines in the Swedish Vascular
Registry.
c Antihypertensive medication or diastolic blood pressure
>110 mmHg.
d Body mass index (BMI) with deﬁnition according to the World
Health Organization.
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rience, the mean ratio was 1.30 (95% CI 1.09e1.55,
p ¼ .005). When stratiﬁed by operator experience, the
mean ratio for operators at proﬁciency level was 1.25 (95%
CI 1.05e1.49, p ¼ .014) and for operators at the basic level
it was 1.33 (95% CI 1.01e1.75, p ¼ .044). The operators at
the basic level (n ¼ 59) took a median of 22.2 minutes
closure time and those at the proﬁciency level (n ¼ 40) a
median of 11.1 minutes. Adjusted for BMI (normal weight,
overweight and obesity) the regression analysis showed
mean ratio of 1.59 (95% CI 1.28e1.96, p < .001). Stratiﬁed
on BMI, normal weight showed a mean ratio of 1.83 (95% CI
1.36e2.46, p < .001), overweight 1.41 (95% CI 0.99e2.02,
p ¼ .058) and obesity 1.61 (95% CI 0.92e2.82, p ¼ .087).
Adjusted for BMI and operator experience the mean ratio
was 1.31 (95% CI 1.09e1.57, p ¼ .005).Complications
There were no signiﬁcant difference in complications,
p¼ .18 (log rank test) (Fig. 3 and Table 3) or reinterventions,
p ¼ .14 (log rank test) (Fig. 4) between the two groups. Two
patients with persistent bleeding in the FST group had a
primary closure of the femoral artery entry site and one of
them had excessive blood loss and peri-operative cardiac
arrest and was resuscitated. Nine patients in the Prostar
group had bleeding complications that were treated with an
arterioraphy (n¼ 5), a fascia suture (n¼ 3), or with Vasoseal
(Datascope Corp., Montvale, NJ, USA) devices (n ¼ 1).
Technical problems with the Prostar device occurred with
needle entrapment in one case, and in another the sutures
were deployed outside the vessel. They were solved by an
open repair and a fascia suture respectively.
Post-operative complications relating to the main access
site were recognized in ﬁve patients after FST. One patient
Figure 3. KaplaneMeier plot of time to ﬁrst access related
complication (index site) in fascia suture technique (FST) and
Prostar. p ¼ .18 (log rank test).
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performed in two patients: one combined with patch and
iliac stent, and one suffering local neuralgia had the fascia
suture removed successfully. One local hematoma was
treated conservatively. In the Prostar group one patient
suffered acute ischemia on the ﬁrst postoperative day. A
plaque dissection was conﬁrmed, requiring a thromboen-
darterectomy. The total peri-operative and immediate post-Table 3. Number of access related (index site) complications.
FST
n ¼ 48
Peri- and post-operative complications
Peri-operative complications
Bleeding 2 (4%)
Technical error with device 0 (0%)
Total 2 (4%)
Post-operative complications
Bleeding 2 (4%)
Thrombosis 2 (4%)
Stenoses 0 (0%)
Neuralgia 1 (2%)
Total 5 (10%)
Total complications before discharge 7 (15%)
Complications after discharge
Complications from discharge to 1 month
Hematoma 1 (2%)
Wound infection 0 (0%)
Pseudoaneurysm 0 (0%)
Total 1 (2%)
Complications from 1 month to 6 monthsc
Pseudoaneurysm 1 (2%)
Total 1 (2%)
Total complications from discharge to 6 monthsc
2 (4%)
Data are presented as number of patients and percentage.
a Evaluated by chi-square test or Fischer exact test when appropriate.
b Adjusted for operator level (proﬁciency/basic) by logistic regression
group.
c One patient in FST and three patients Prostar lost to follow up at 6
d One patient had same type of complication twice after discharge.operative complication rate (technical failure) was 15% (7/
48) for FST and 24% (12/51) for Prostar (Table 3). The
technical failure rate for operators at the proﬁciency level
was 5% (2/40) compared with 29% (17/59) for those at the
basic level, (p ¼ .003). The proﬁciency level group had a
technical failure rate of 4% (1/26) for FST and 7% (1/14) for
Prostar (p ¼ 1.00), while corresponding rates for the basic
level group were 27% (6/22) for FST and 30% (11/37) for
Prostar (p ¼ .84).
Clinical follow up was performed at 1 and 6 months. At 1
month a hematoma in the FST group had resolved; in the
Prostar group one pseudoaneurysm had resolved, while
another patient had a wound infection successfully treated.
There were no complications at 6 months. One patient in
the Prostar group died at home from unknown reason
before the 6 month follow up (Table 3).Measurements
Nine patients had asymptomatic stenoses on pre-operative
ultrasound and/or at the 6 month examination (Table 4).
One patient (2%) in the FST group had a pseudoaneurysm
(11 mm), as did three patients (6%) in the Prostar group
(12e41 mm) (Table 3). None of these pseudoaneurysms
resulted in active treatment. There was no venous
thrombosis.Prostar Unadjusteda Adjustedb
n ¼ 51 OR (p-value) OR (p-value)
9 (18%)
2 (4%)
11 (22%) 6.3 (.01) 4.6 (.06)
0 (0%)
0 (0%)
1 (2%)
0 (0%)
1 (2%)
12 (24%) 1.8 (.26) 1.2 (.72)
0 (0%)
1 (2%)
1 (2%)
2 (4%)
3 (6%)
3 (6%)
4 (8%)d
, odds ratio (OR) above 1 indicate more complications in Prostar
month.
Figure 4. KaplaneMeier plot of time to ﬁrst reintervention in fascia
suture technique (FST) and Prostar. p ¼ .14 (log rank test).
Figure 5. Box-plot of ankleebrachial pressure index (ABI) before
and after access closure by fascia suture technique (FST) and
Prostar. Note. The boxes represent the 75th and 25th percentiles;
the horizontal bar within a box is the median; the whiskers are max
and min if no outliers are present, otherwise open circles (B)
represent outliers: values >1.5 box lengths from the 25th or 75th
percentile.
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ABI measurements were completed in 89 patients (90%).
Five patients had incompressible arteries due to Moncke-
berg’s sclerosis. Four patients did not complete the mea-
surement and one patient died before the 6 month follow
up. ABI values did not change signiﬁcantly from the pre-
operative values for any group (Fig. 5).Access closure cost
There was a signiﬁcant cost difference in favor of FST, with a
median difference of V800 (95% CI 710e927, p < .001)
with a negligible cost for the fascia suture material. The
procedure time for FST was shorter, resulting in a lower
procedural cost; however, more re-operations after FST
(n ¼ 4) than Prostar (n ¼ 1) reduced this difference. In the
Prostar group, 50% of the total cost was attributable to the
materials (Table 5).DISCUSSION
The data are in favor of FST as the faster method to achieve
closure of the access site for operators at both the basic and
the proﬁciency level. The complication rate seems favorable
even though this trial was not powered to address anyTable 4. Descriptive data of patients with ultrasound veriﬁed
stenosis pre-operatively and at 6 months follow up (index site).
Access closure
method
Pre-operative 6 months
US stenosis ABI US stenosis ABI
Prostar No 0.50 Yes 0.75
Prostar Yes 0.46 Yes 0.66
Prostar No 0.94 Yes 1.07
FST Yes 0.78 No 0.86
Prostar Yes 0.73 Yes 0.68
FST Yes 1.06 No 1.17
Prostar Yes 1.15 Yes 1.07
FST No 1.33 Yes 1.33
Prostar No 1.08 Yes 1.04
Note. Data presented only on patients with pre-operative and/or 6
months US stenosis. US ¼ ultrasound; ABI ¼ ankleebrachial
pressure index; FST ¼ fascia suture technique.difference in complication rates. The shorter closure time
had a positive economic effect, but the main reason why
the fascia suture was signiﬁcantly cheaper was the reduc-
tion of material costs while the complication rate was kept
at an equal level. In this study it has also been shown that
fascia suture can work as a bailout procedure for a failed
Prostar suture.
Comparison with other studies
In many publications presenting percutaneous access for
EVAR common reasons not to apply SMCD have been
obesity and calciﬁcation,5,7e9,11,12,21 although successful
outcomes have been reported for this group of patients.22
Mousa et al.23 reported severely calciﬁed arteries as pre-
dictive of conversion but BMI was a non-signiﬁcant pre-
dictor. Calciﬁcation and BMI were not exclusion criteria in
the study. FST has a potential advantage in calciﬁed arteries,
as the stitches do not involve the vessel wall. Previous groin
surgery has also been a reason to exclude patients from
percutaneous EVAR.11 It was not possible to evaluate the
effect of a scarred groin (present in just four patients), but
in the authors’ experience scarred tissue works as well as
normal fascia for FST.
There was a strong relationship between reduced tech-
nical failure and high level operator experience in line with
previous reports for Prostar, which indicates an important
learning process.24,25 Metcalfe et al.25 used a cutoff of 20
supervised deployments of Prostar to deﬁne a proﬁciency
level, and 15 cases constituted the request for “license.” In
the hands of experienced operators, the complication rate
was 4e7%, close to earlier reports for either technique.4,15e
18,22 The closure time was, however, shorter for FST
regardless of experience level.
Table 5. Cost analysis for access closure and access related complications (index site).
FST (n ¼ 48) Prostar (n ¼ 51) Median difference (95% CI)
Total cost
Per patient in Euro, median (range) 349 (160e4318) 1,181 (920e2866) 800 (710e927)
Cost subgroups
Primary procedure,a sum cost in Euro (%) 21,631 (71%) 33,112 (46%)
Material, sum cost in Euro (%) 506 (2%) 35,548 (50%)
Secondary procedure,b sum cost in Euro (%) 8,235 (27%) 1,674 (2%)
In-hospital care,c sum cost in Euro (%) 0 (0%) 1,286 (2%)
Total, sum cost in Euro (%) 30,372 (100%) 71,620 (100%)
Note. Data are presented in Euro (1 Euro ¼ 8.50 Swedish krona). FST ¼ fascia suture technique.
a Calculated as Euro 27/minute.
b Calculated as Euro 22/minute.
c Calculated as Euro 643/day.
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pre-operatively, and the few post-operative complications
could be solved before discharge. Three patients had minor
complications detected at clinical follow up. Small pseu-
doaneurysms after FST have been described in up to 14% at
the 1 month follow up,18 but they usually seal spontane-
ously and reinterventions are rarely required. The same
observations have been made after Prostar.26 In this study
pseudoaneurysms were rare, 2% after FST and 6% after
Prostar, at 6 month follow up. A more aggressive surveil-
lance protocol, as suggested,27 seems unjustiﬁed.
Strengths and limitations
The strength of this trial is that no anatomical exclusion
criteria were accepted except the presence of an aneurysm
at the access site. The two participating centers had
different protocols; in one, FST was the routine technique
and in the other Prostar. The two techniques were applied
and harmonized with a strict protocol for both centers.
Ahead of the study the teams trained each other in order to
get “closure license” for both techniques. Fifteen pro-
cedures were recognized as a minimum request for a “li-
cense” and 60 procedures were used as an arbitrary
measure of proﬁciency. The “license” was achieved by car-
rying out a few procedures during supervision followed by a
self reported statement by the participating doctors. It may
be a limitation that no formal examination was performed.
Technical failure was initially discussed as a primary
endpoint. Signiﬁcantly more patients had to be included,
which was not realistic due to problems with patient
recruitment, based on the limited use of FST when the
study was designed. The primary endpoint was access
closure time and a limitation is that the procedure time
could be inﬂuenced in an open study, a risk reduced by
detailed stopwatch timekeeping. Another limitation is that
the outcome of the randomization was skewed with regard
to operator experience and BMI, and is the reason why
statistical adjustments were made.
The study protocol did not require strict guidelines for
post-operative management and the period of supine rest
was not deﬁned. Whether early mobilization increases the
risk of bleeding or pseudoaneurysm formation cannot be
concluded. A strength of the study is that no externalcompression was allowed, whereas it was in another
report.17
Vascular surgeons performed the majority of the pro-
cedures, which may have been beneﬁcial for FST as it uti-
lizes standard surgical materials and technique. The Prostar
technique has the advantage of maintaining EVAR as a
strictly percutaneous procedure while the FST requires a
limited groin dissection to the femoral fascia, which is an
uncommon procedure for interventional radiologists. It
might be a limitation that a procedures log and a protocol
with standardized questions were not established during
the training phase.
Future work
Logistically it was not possible to include ruptured aortic
aneurysms in this trial. However, FST was routinely imple-
mented in the repair of these cases. The FST did not reach
the 10-minute threshold for a clinically relevant difference,
but with the advantage of no need for pre-suturing, FST is
probably of greater beneﬁt in emergency situations than in
elective operations.
With increased FST experience, as gained in this study, it
has been possible to identify some risk factors for failure.
Puncture above the inguinal ligament should be avoided, as
there is no femoral fascia to cover the access hole at this
location. A careful evaluation of the computed tomography
image to determine the relationship between the femoral
bifurcation and skeletal reference points is useful to ensure
an optimal puncture site. Ultrasound guided puncture is
valuable, as is angiography, to conﬁrm an appropriate
puncture site before exchange to a large bore sheath takes
place.
The stitches of the suture must be sufﬁciently deep in
order to achieve tissue for the “fascia plug.” On the other
hand, stitches that are too deep may cause obstruction. The
study showed that post-operative complications (bleeding,
thrombosis) were slightly more common in the FST group.
By using a duplex Doppler device, the blood ﬂow velocity
can be evaluated peri-operatively to prevent arterial
constriction.
In conclusion, the fascia suture technique is a faster and
cheaper technique than the suture-mediated closure de-
vice, Prostar XL. The trial was not powered to show possible
RCT of Fascia Suture Versus Suture Mediated Closure Device 173differences in complication rates between the two tech-
niques. A signiﬁcant independent risk factor was shown to
be operator experience, independent of which closure
technique was used. To get an optimal outcome, a proper
training program should be implemented.
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